Over-the-Counter Medication Policies in Childcare Settings
A child arrives at daycare with a low-grade fever. The parent mentions they gave ibuprofen this morning but leaves a bottle of acetaminophen "just in case." The provider has 14 other children, no nurse on staff, and a licensing standard they are legally required to follow. What happens next is governed by a framework that most parents never read — until something goes wrong.
Over-the-counter (OTC) medication policies in childcare settings define when, how, and under what authorization a provider may administer non-prescription drugs to children in their care. These policies operate at the intersection of state licensing codes, health department guidance, and facility-level procedures, and they carry real consequences: improper administration can trigger license suspension, civil liability, or direct harm to a child.
Definition and scope
An OTC medication in the childcare context is any non-prescription drug — acetaminophen, ibuprofen, diphenhydramine, topical antibiotic ointments, antifungal creams, saline drops — that a consumer may purchase without a prescriber's order. The term sounds simple. The regulatory handling is not.
The American Academy of Pediatrics (AAP) draws a clear line between medication storage, administration, and documentation — and childcare licensing standards in every state echo that three-part structure. A provider who stores a bottle of children's Tylenol in a locked cabinet is operating in a different regulatory space than one who opens it and doses a child. The former is a storage question; the latter is a medical act.
Scope matters here because types of childcare settings are not treated uniformly. A licensed family childcare home, a center-based program serving 80 children, and a school-age afterschool program all fall under distinct licensing categories — and their OTC medication obligations can differ substantially even within the same state. Head Start programs, for instance, operate under federal Performance Standards (45 CFR Part 1302) that impose documentation and parental consent requirements regardless of what the host state requires.
How it works
The operational framework for OTC medication administration in childcare typically follows four discrete steps, regardless of state:
-
Written authorization from the parent or legal guardian — most states require a signed permission form specific to each medication, including the drug name, dosage, and the condition for which it may be given. A blanket "permission to medicate" form is insufficient under childcare licensing requirements in states including California and New York.
-
Medication arrives in its original, labeled container — providers generally cannot accept a medication transferred into an unlabeled bag or cup. The original packaging establishes the drug name, concentration, and manufacturer's dosing instructions.
-
Administration by a designated, trained staff member — not every staff member at a center is authorized to administer medication. Many states require that the administering staff member hold a current medication administration training certificate. The childcare provider credentials landscape increasingly includes this training as a baseline competency.
-
Documentation at the time of administration — the time given, dose, route, child's response, and the name of the administering staff member must all be recorded. Some states require a parent signature acknowledging the dose was given.
The medication administration in childcare standards published by the National Resource Center for Health and Safety in Child Care and Early Education (NRC) represent the most widely referenced national framework, though they carry no regulatory force on their own. States adopt, adapt, or ignore them at their discretion.
Common scenarios
Fever reduction: The most common OTC administration request. Acetaminophen and ibuprofen are both frequently authorized — but ibuprofen is contraindicated for infants under 6 months, a dosing boundary that childcare staff must be prepared to apply correctly. A 2020 review published in Pediatrics confirmed that dosing errors with these two drugs are among the most frequent medication mistakes in young children.
Allergy symptoms: Diphenhydramine (Benadryl) sits in a complicated category. It is technically OTC, but its sedative effects make many licensing bodies treat it with heightened scrutiny. Some state regulations prohibit its administration in childcare settings without a physician's written order — effectively reclassifying it functionally as a prescription medication for childcare purposes.
Topical treatments: Sunscreen and insect repellent are OTC products, but the AAP classifies DEET-containing repellents as requiring parental authorization and cautions against use on children under 2 months. Sunscreen authorization is required by law in a subset of states even when a product is labeled SPF 30 and sold without a prescription.
Teething products: The FDA issued a safety communication warning against the use of benzocaine oral products in children under 2 due to risk of methemoglobinemia — a fact that childcare health and hygiene standards should reflect in provider training materials.
Decision boundaries
The clearest line in OTC policy: provider discretion ends where parental authorization begins. A provider may not decide, independently, that a child appears uncomfortable and administer acetaminophen. Even if the medication is on the shelf, even if the dosing is obvious, even if the parent "would probably want it" — the absence of prior written authorization is a hard stop in every state licensing framework reviewed by the NRC.
The second boundary involves illness exclusion overlap. If a child's condition meets illness exclusion criteria — a fever above 101°F, for example — administering a fever reducer to bring the temperature down and keep the child in care creates a direct policy conflict. The safety context for childcare treats this as a risk escalation scenario, not a medication question.
The third boundary is product category ambiguity. Melatonin, herbal remedies, and homeopathic products are sold OTC but are not regulated as drugs by the FDA under the same standards. Many state licensing codes have not caught up to the proliferation of these products, leaving providers in a gap where parental permission exists but the product itself lacks established pediatric dosing data. The safest documented position for a provider in that gap: treat unverified OTC products the same as prescription medications and require a physician's written authorization before administration.